Home News PMPRB

28

Jun2024

PMPRB Releases Long Awaited Discussion Guide as Phase 2 of the New Guidelines Consultation Process

On Wednesday, June 26th, PMPRB initiated Phase 2 of the consultation process by publishing the Discussion Guide that will help shape future guidelines. They have indicated that changes to the Guidelines are necessary to address their new legislative and jurisprudential reality and are committed to modernizing and simplifying ... Read More

14

Nov2023

PMPRB Provides Themes For First Step Of Guidelines Consultation; Announces Appointments Of Two New Board Members

First Step of The New Guidelines Consultation Announced On October 25, 2023, the Patented Medicine Prices Review Board (PMPRB) released details on the first  of its two-step consultation process for developing its new set of price regulatory guidelines. PMPRB will send invitations to stakeholders for ... Read More

13

Nov2023

PMPRB Invites Stakeholder Feedback on Scoping Paper on Themes for New Guidelines

On November 10, 2023, the Patented Medicine Prices Review Board (PMPRB) launched first phase of its consultation process towards development of new price regulatory Guidelines. PMPRB published its Scoping Paper for the Consultations on the Board’s Guidelines and invited feedback to be provided either ... Read More

02

Oct2023

PMPRB Publishes Final Decision on Amended Interim Guidance

On September 27, 2023, the Patented Medicine Prices Review Board (PMPRB) published its final decision regarding the Amended Interim Guidance first proposed on June 20, 2023.Effective immediately, the proposed amendments to the Interim Guidance are implemented without changes, notwithstanding the concerns raised by many of the ... Read More

11

Jul2023

Updates on PMPRB Activities in June 2023 NEWSletter

On June 6, 2023, the Patented Medicine Prices Review Board (PMPRB) released its first NEWSletter of 2023, providing updates on recent activities among the Board and Board staff. Updates from the NEWSletter and PDCI’s insights on potential implications are summarized below.  Despite recent quietness from PMPRB on its ... Read More

11

Jul2023

PMPRB Launches Consultation on its Amendment to the Interim Guidance RE: New Medicines

On June 20, 2023, PMPRB published proposed amendments to the Interim Guidance relating to  New Medicines. PMPRB has invited stakeholders to comment on the approach before August 21, 2023 (60-day consultation). After stakeholder consultation, a new set of guidelines is anticipated to be finalized in 2024.... Read More

07

Mar2023

Mélanie Bourassa Forcier References “Dialogue of the Deaf” Between PMPRB and Industry Among Reasons for her Resignation from PMPRB

In the wake of media attention around recent high-profile resignations from PMPRB, Melanie Bourassa Forcier, former Acting Chairperson of the PMPRB who resigned in December, came forward to "rectify the facts” about her reasons for resigning this past weekend.In her 5-page letter dated March 3rd and published on ... Read More

24

Feb2023

Doug Clark Resigns from PMPRB

On February 24, 2023, Doug Clark announced he is stepping down from his position as Executive Director of the PMPRB after almost a decade with PMPRB. Clark will continue to serve as a special advisor to the Board as he transitions to retirement from the federal public service. ... Read More

24

Feb2023

PMPRB Board Member Resigns

On February 23, 2023, Matthew Herder, a PMPRB Board Member since 2018, publicly announced his resignation from the PMPRB. He shared his resignation letter on his personal twitter page today. The letter, which he notes was submitted to Health Minister Jean-Yves Duclos on Monday, outlines his reasons for parting ways with ... Read More

13

Feb2023

PMPRB New Chairperson

On Wednesday, February 1, 2023, the Minister of Health announced the appointment of Thomas J Digby as the new Chairperson for the PMPRB. This nomination comes after over a year of being vacant when Dr. Mitchell Levine completed his five-year term tenure on November 2021. Thomas J. Digby ... Read More